Supported by an educational grant from Axsome Therapeutics, Inc.

News

Pharmacogenomic Test Improves MDD Response and Remission Outcomes

Clinician use of a specific weighted multigene pharmacogenomic (PGx) test significantly improved outcomes in adult patients with

All News

Investigational MDD Drug Shows Favorable Outcome in Interim Analysis

An ongoing phase 2b trial investigating adjunctive ALTO-300 in patients with major depress

Evidence Lacking for TRD Treatment Effectiveness in Older Adults, Review Finds

A systematic review published in BMJ Mental Health found weak quality evidence to support the effectiveness of several commonly prescribed pharmacological and non-pharmacological intervent

Post Partum Hormonal Contraception Use Linked With Heightened Depression Risk

The initiation of hormonal contraception post partum was associated with an immediate increase in

New Study Finds Quetiapine More Effective Than Lithium in Reducing Treatment-Resistant Depression Symptoms

Quetiapine may be more clinically effective than lithium as an augmentation option for reducing symptoms of treatment-resistant depression (TRD), a type of